Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros











Intervalo de año de publicación
1.
Artículo en Inglés | MEDLINE | ID: mdl-36691598

RESUMEN

Background: Nonalcoholic fatty liver disease (NAFLD) is the most common hepatic disorder, affecting 22-28% of the adult population and more than 50% of obese people all over the world. Modulation of the fatty acids in diet as a means of prevention against nonalcoholic fatty liver disease in animal models (NAFLD) remains unclear. The treatment of NAFLD has not been described in specific guidelines so far. Thus, the justification for the study is to check modifications in macronutrients composition, fatty acids, in particular, play a significant role in the treatment of NAFLD regardless of weight loss. Aim: To investigate different vegetable oils in prevention and progression of NAFLD in animal models. Methods: For the experiment were used fifty C57BL/6J mice male fed with high fat and fructose diet (HFD) to induce the NAFLD status and they received different commercial vegetable oils for 16 weeks to prevent steatosis. Liver steatosis and oxidative stress parameters were analyzed using biochemical and histological methods. Fatty acids profile in the oils and in the liver samples was obtained. Results: The high fat and fructose diet led to obesity and the vegetable oils offered were effective in maintaining body weight similar to the control group. At the end of the experiment (16 weeks), the HFHFr group had a greater body weight compared to control and treated groups (HFHFr: 44.20 ± 2.34 g/animal vs. control: 34.80 ± 3.45 g/animal; p < 0.001; HFHFr/OL: 35.40 ± 4.19 g/animal; HFHFr/C: 36.10 ± 3.92 g/animal; HFHFr/S: 36.25 ± 5.70 g/animal; p < 0.01). Furthermore, the HFD diet has caused an increase in total liver fat compared to control (p < 0.01). Among the treated groups, the animals receiving canola oil showed a reduction of hepatic and retroperitoneal fat (p < 0.05). These biochemical levels were positively correlated with the hepatic histology findings. Hepatic levels of omega-3 decreased in the olive oil and high fat diet groups compared to the control group, whereas these levels increased in the groups receiving canola and soybean oil compared to control and the high fat groups. Conclusion: In conclusion, the commercial vegetable oils either contributed to the prevention or reduction of induced nonalcoholic fatty liver with high fat and fructose diet, especially canola oil.

2.
Cells ; 10(7)2021 07 08.
Artículo en Inglés | MEDLINE | ID: mdl-34359902

RESUMEN

The microbiota of the gut-lung axis affects local and far-reaching immune responses and might also trigger chronic and inflammatory diseases. We hypothesized that gut dysbiosis induced by obesity, which coexists in countries with a high tuberculosis burden, aggravates the host susceptibility and the pulmonary damage tolerance. To assess our hypothesis, we used a model of high-fat diet (HFD)-induced obesity, followed by infection of C57BL/6 mice with Mycobacterium tuberculosis. We showed that obesity increased the susceptibility, the pulmonary inflammation and IFN-γ levels in M. tuberculosis-infected mice. During the comorbidity obesity and tuberculosis, there is an increase of Bacteroidetes and Firmicutes in the lungs, and an increase of Firmicutes and butyrate in the feces. Depletion of gut microbiota by antibiotic treatment in the obese infected mice reduced the frequencies of CD4+IFN-γ+IL-17- cells and IFN-γ levels in the lungs, associated with an increase of Lactobacillus. Our findings reinforce the role of the gut-lung axis in chronic infections and suggest that the gut microbiota modulation may be a potential host-directed therapy as an adjuvant to treat TB in the context of IFN-γ-mediated immunopathology.


Asunto(s)
Disbiosis/etiología , Disbiosis/microbiología , Interferón gamma/biosíntesis , Obesidad/complicaciones , Obesidad/microbiología , Neumonía/microbiología , Tuberculosis/complicaciones , Inmunidad Adaptativa , Animales , Carga Bacteriana , Susceptibilidad a Enfermedades , Disbiosis/inmunología , Trasplante de Microbiota Fecal , Heces/microbiología , Femenino , Leucocitos/metabolismo , Pulmón/inmunología , Pulmón/microbiología , Pulmón/patología , Ratones Endogámicos C57BL , Microbiota , Obesidad/inmunología , Neumonía/inmunología , Tuberculosis/inmunología
3.
J Breath Res ; 14(4): 041002, 2020 08 14.
Artículo en Inglés | MEDLINE | ID: mdl-32663815

RESUMEN

Fructose intake is associated with increased consumption of processed foods, specifically in the context of nutritional supplements. To assess gastrointestinal symptoms and hydrogen production after the ingestion of a fructose solution in runners, healthy and sick persons. Hydrogen test (H2 test) was performed after the intake a solution with 50 g fructose along with the application of a questionnaire to evaluate the gastrointestinal symptoms during the H2 test in three groups: Athletes group (AG); control group (CG) with healthy subjects; and non-alcoholic fatty liver disease group (NAFLDG). Statistical analysis was performed with analysis of variance at a p < 0.05 significance level. The AG was the largest H2 producer followed by the CG with significant difference between the AG and NAFLDG (p ≤ 0.05). Most participants remained asymptomatic, but the strongest correlation was the symptom of bloating GC (R = 0.625), eructation in NAFLD (R = 0.481) and diarrhea in CG (R = 0.345) and AG (R = 0.338) The result of the present study suggests the production of hydrogen by the colon following the administration of fructose is higher in athletes compared with healthy individuals and persons with NAFLD, showing that fructose intake may be an interesting point of dietary management, especially in elite professionals.


Asunto(s)
Fructosa/química , Hidrógeno/química , Intestinos/fisiopatología , Enfermedad del Hígado Graso no Alcohólico/fisiopatología , Carrera/fisiología , Adulto , Femenino , Humanos , Masculino
4.
Nutrition ; 70: 110607, 2020 02.
Artículo en Inglés | MEDLINE | ID: mdl-31743810

RESUMEN

OBJECTIVE: The aim of this study was to evaluate the applicability of phase angle (PhA) as a severity indicator of chronic liver diseases. METHODS: We examined the medical records of 54 patients-27 with hepatocellular carcinoma (HCC) and 27 with non-alcoholic fatty liver disease (NAFLD). The patients were ≥18 y of age. Clinical data, such as Child-Pugh and Barcelona Clinic Liver Cancer (HCC), aspartate aminotransferase-to-platelet ratio index (APRI) and fibrosis (FIB)-4 (NAFLD), nutritional parameters (body mass index [BMI], handgrip strength [HGS], and bioelectrical impedance [BIA] data) were collected. Nutritional Risk Index (NRI) was calculated. Analysis was performed using Mann-Whitney test and analysis of variance. Simple multiple linear regression for predictions (Child-Pugh in HCC, APRI and FIB-4 in NAFLD). Receiver operating characteristic curve was estimated to search a cutoff for PhA. For survival, we used the Kaplan-Meier estimator. To verify whether PhA affected patients' survival, we used the Mantel-Haenszel. RESULTS: The prevalence of cirrhosis was high in HCC (n = 25) and low in the NAFLD (n = 4). No patient was classified as undernourished based on BMI; however, NRI showed that 74.1% of patients with HCC had nutritional risk. Child-Pugh was positively correlated with the edema index (extracellular water/total body water [ECW/TBW]) and negatively correlated with PhA and HGS. Higher Child-Pugh and BCLC scores were associated with worse NRI. APRI and FIB-4 were positively correlated with weight and BMI. A significant difference between groups was found for the median values of R, ECW/TBW, PhA, HGS, and albumin. There was a trend toward lower survival in patients with HCC, according to the cutoff point of 5.1 degrees for PhA. CONCLUSION: PhA was shown to be an independent prognostic indicator for cirrhosis and may be related to survival in these patients.


Asunto(s)
Dieta Saludable/estadística & datos numéricos , Impedancia Eléctrica , Enfermedad Hepática en Estado Terminal/fisiopatología , Pruebas de Función Hepática/estadística & datos numéricos , Índice de Severidad de la Enfermedad , Adulto , Anciano , Peso Corporal , Femenino , Fuerza de la Mano , Humanos , Pruebas de Función Hepática/métodos , Masculino , Persona de Mediana Edad , Fuerza Muscular , Evaluación Nutricional , Estado Nutricional , Valor Predictivo de las Pruebas , Pronóstico , Medición de Riesgo , Albúmina Sérica/análisis
5.
Ribeirão Preto; s.n; 2015. [12] p. tab.
Tesis en Portugués | Sec. Est. Saúde SP, SESSP-CTDPROD, Sec. Est. Saúde SP, SESSP-ACVSES, SESSP-PAPSESSP, Sec. Est. Saúde SP | ID: biblio-1082539

RESUMEN

A crescente incidência de obesidade e comorbidades vinculadas a esta têm ganhado atenção em políticas de Saúde Pública e na pesquisa. O elevado consumo de frutose junto a uma dieta hiperlipídica parece estar diretamente ligada a essas comorbidades, em especial a esteatose hepática. O consumo de óleos vegetais ricos em gorduras monoinsaturadas e poli-insaturadas tem se mostrado benéfico para o tratamento e prevenção dessas comorbidades, porém existem poucos estudos relacionando o uso de tais óleos. Dessa forma, o presente trabalho tem por objetivo avaliar o consumo de óleos vegetais ricos em MUFAs e PUFAs usados comercialmente na prevenção da esteatose hepática analisando parâmetros do metabolismo lipídico hepático e sérico, estresse oxidativo e resistência á insulina. Materiais e métodos: Inicialmente ratos wistar machos foram separados em cinco grupos: Grupo HL * Hiperlipídica, na qual recebeu 50 % de gordura animal; Grupo HL * AZ que receberão 25 % de gordura animal e 25 % de azeite extra virgem; Grupo HL* CN na qual receberão 25 % de gordura animal e 25 % de óleo de canola; Grupo HL* M na qual receberão 25 % de gordura animal e 25 % de óleo de milho; Grupo HL * S na qual receberão 25 % de gordura animal e 25 % de óleo de soja. As análises realizadas serão para verificação de parâmetros lipídicos, estresse oxidativo e resistência à insulina.


Asunto(s)
Humanos , Animales , Cobayas , Ratas , Dieta Alta en Grasa , Fructosa , Hígado Graso , Obesidad/prevención & control , Ácidos Grasos Insaturados , Ácidos Grasos Monoinsaturados , Aceites de Plantas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA